Brexit = upheaval for drug makers

Will the European Medicines Agency (EMA) need to re-located after Brexit? According to a Reuters story, the answer is yes. The EMA is a London-based organization that approves treatments for all EU countries. As the UK leaves the EU, however, EMA is expected to have to relocate. 600 individuals work for EMA. More important is…

Patient perspective on cancer care funding

Improvement in survival (a.k.a. efficiacy) clearly are important, but what other factors matter?  According to a systematic literature review by MacLeod, Harris and Mahal (2016), these factors include: patients favour funding for cancer medicines that improve health outcomes demonstrated by ‘clinical efficacy’ [Oh et al.], ‘prolonged survival’ [Goldman et al., Seabury et al. Lakdawalla et al.] and/or…

Infectious Disease: Themes

An interesting post by Nicolas Bagley at the Incidental Economist provides a brief overview of a class he taught on infectious diseases and the law.  Looking at diseases ranging from cholera, Spanish flu, polio, AIDS, SARS, and Ebola, Bagley claims that ten key themes emerged: Governments are typically unprepared, disorganized, and resistant to taking steps…

Avoiding Lead poisoning

Lead poisoning, perhaps surprisingly, is still a major problem in the U.S. Lead poisoning in the water supply in Flint, Michigan is grabbing all the headlines, but other sources of lead poisoning are also problematic. John Oliver has even dedicated an entire show to the problem of lead poisoning in the U.S. How do you…

What is the FDA doing about opioids?

The FDA is planning to put additional scrutiny on the use and approval of opioids in order to prevent opioid abuse and addiction.  Here is their plan: Re-examine the risk-benefit paradigm for opioids and ensure that the agency considers their wider public health effects Convene an expert advisory committee before approving any new drug application for an…

Health in Baltimore

Baltimore is in the news, and not for the best reasons.  The arrest and eventual death of Freddie Gray have unleashed a series of protests and riots.  One conference where the Healthcare Economist had a poster presentation–the American Heart Association (AHA) Quality of Care and Outcomes Research (QCOR) Scientific Sessions (conference) was cancelled this week due…